QRG Capital Management’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$519K Buy
6,626
+662
+11% +$45.1K ﹤0.01% 851
2026
Q1
$385K Sell
5,964
-289
-5% -$20.4K ﹤0.01% 864
2025
Q4
$421K Buy
6,253
+877
+16% +$59K ﹤0.01% 813
2025
Q3
$394K Buy
5,376
+321
+6% +$21.3K ﹤0.01% 801
2025
Q2
$263K Buy
5,055
+644
+15% +$36.6K ﹤0.01% 1003
2025
Q1
$281K Buy
+4,411
New +$256K ﹤0.01% 928
2024
Q4
– Sell
-4,279
Closed -$245K – 1104
2024
Q3
$245K Buy
+4,279
New +$245K ﹤0.01% 976

Other funds holding HALO

QRG Capital Management's HALO Position: Q2 2026 in Review

QRG Capital Management increased its Halozyme (HALO) stake by 11% in Q2 2026, buying an estimated $45.1K and bringing the position to 6,626 shares worth $519K. The position accounts for ﹤0.01% of the portfolio, ranked #851.

QRG Capital Management first reported a position in HALO in Q3 2024 and has held it in 7 quarters since. 674 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • QRG Capital Management held 6,626 shares of Halozyme worth $519K as of Q2 2026.
  • QRG Capital Management bought 662 Halozyme shares in Q2 2026, an estimated $45.1K.
  • Halozyme made up ﹤0.01% of QRG Capital Management's portfolio in Q2 2026, its #851 holding.
  • QRG Capital Management first reported a position in Halozyme in Q3 2024 and has held it in 7 quarters since.
  • 674 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on QRG Capital Management's 13F filing for Q2 2026, filed 14 Jul 2026.